Kazuhiro Nagahira
- cPLA2α inhibitor ASB14780 suppresses airway MMP-9 production and improves respiratory function in cigarette-smoke induced modelBy Maki Terakawa, Megumi Goto, Toshiyuki Tomoo, Toyoko Katayama, Yasuhiro Hayashi and Kazuhiro NagahiraMaki Terakawa1Faculty of Pharmacology I, Asubio Pharma Co., Ltd., Kobe, JapanMegumi Goto1Faculty of Pharmacology I, Asubio Pharma Co., Ltd., Kobe, JapanToshiyuki Tomoo2Faculty of Pharmaceutical Chemistry, Asubio Pharma Co., Ltd., Kobe, JapanToyoko Katayama3Faculty of R&D Administration, Asubio Pharma Co., Ltd., Kobe, JapanYasuhiro Hayashi4Faculty of Exploratory Technology, Asubio Pharma Co., Ltd., Kobe, JapanKazuhiro Nagahira1Faculty of Pharmacology I, Asubio Pharma Co., Ltd., Kobe, Japan
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.